Greenstone Biosciences, Inc. and Intel Corp. Launch Strategic Collaboration 

Intel and Greenstone are partnering to accelerate the development of new medicines. The collaboration combines Greenstone’s expertise in human genetics and biology with Intels specialized computing technology to improve the processing, storage and analysis of large amounts of data.

Greenstone has developed the world’s largest human biobank of induced pluripotent stem cells (iPSCs), providing a valuable resource for AI-driven drug discovery and research.

The collaboration also supports the growing adoption of New Approach Methodologies (NAMs), encouraged by recent U.S. FDA initiatives. These approaches are designed to complement traditional animal testing and improve the relevance of preclinical research for human health.

Read More:Alcott HR Appoints Michael Pascucci as Director of Strategic Projects

By combining human cell-based models, large-scale population data, and AI-powered analytics, Greenstone and Intel aim to improve drug safety testing and help accelerate the development of new medicines.

“This collaboration represents an important step toward more human centered drug development,” said Joseph C. Wu, M.D., Ph.D., Co Founder of Greenstone Biosciences and Director of the Stanford Cardiovascular Institute (SCVI). By combining our iPSC-based systems with Intel’s advanced computing architecture, we identify patient-specific response patterns, improve prediction of adverse drug effects, and advance new medicines more quickly and at a lower cost.”

About Greenstone Biosciences, Inc.

Founded in 2022 by Joseph Wu and Jade Chao, Greenstone Biosciences is a biotechnology company based in Stanford Research Park, California. The company uses human induced pluripotent stem cells (iPSCs), artificial intelligence, computational biology, and pharmacogenomics to accelerate drug discovery and development. Greenstone’s goal is to transform the traditional drug discovery process into a faster, more efficient, and data-driven platform that helps bring new therapies to patients more quickly.

About Intel

Intel is a global technology company focused on shaping the future through innovation. Its technologies power a wide range of products and solutions that support breakthroughs, and improve everyday life. By developing advanced computing, and semiconductor technologies, Intel helps drive progress across industries and contributes to creating a better future for people around the world.

Read More:Bruce Broussard and Karen Lynch joining Optura as Strategic Advisors